These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

56 related articles for article (PubMed ID: 16012879)

  • 21. Micro-colony array based high throughput platform for enzyme library screening.
    Pohn B; Gerlach J; Scheideler M; Katz H; Uray M; Bischof H; Klimant I; Schwab H
    J Biotechnol; 2007 Mar; 129(1):162-70. PubMed ID: 17174002
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Cell-based high-content screening of small-molecule libraries.
    Korn K; Krausz E
    Curr Opin Chem Biol; 2007 Oct; 11(5):503-10. PubMed ID: 17931958
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Screening for developmental delay in the setting of a community pediatric clinic: a prospective assessment of parent-report questionnaires.
    Rydz D; Srour M; Oskoui M; Marget N; Shiller M; Birnbaum R; Majnemer A; Shevell MI
    Pediatrics; 2006 Oct; 118(4):e1178-86. PubMed ID: 17015506
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Simple method for production of randomized human tenth fibronectin domain III libraries for use in combinatorial screening procedures.
    Garcia-Ibilcieta D; Bokov M; Cherkasov V; Sveshnikov P; Hanson SF
    Biotechniques; 2008 Apr; 44(4):559-62. PubMed ID: 18476822
    [TBL] [Abstract][Full Text] [Related]  

  • 25. SeleX-CS: a new consensus scoring algorithm for hit discovery and lead optimization.
    Bar-Haim S; Aharon A; Ben-Moshe T; Marantz Y; Senderowitz H
    J Chem Inf Model; 2009 Mar; 49(3):623-33. PubMed ID: 19231809
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Investigation of the incidence of "undesirable" molecular moieties for high-throughput screening compound libraries in marketed drug compounds.
    Axerio-Cilies P; Castañeda IP; Mirza A; Reynisson J
    Eur J Med Chem; 2009 Mar; 44(3):1128-34. PubMed ID: 18692938
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Rational design of macrolides by virtual screening of combinatorial libraries generated through in silico manipulation of polyketide synthases.
    Zotchev SB; Stepanchikova AV; Sergeyko AP; Sobolev BN; Filimonov DA; Poroikov VV
    J Med Chem; 2006 Mar; 49(6):2077-87. PubMed ID: 16539396
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Molecular diversity in engineered protein libraries.
    Barakat NH; Love JJ
    Curr Opin Chem Biol; 2007 Jun; 11(3):335-41. PubMed ID: 17548238
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Solid-phase synthesis of a peptide-based P,S-ligand system designed for generation of combinatorial catalyst libraries.
    Christensen CA; Meldal M
    J Comb Chem; 2007; 9(1):79-85. PubMed ID: 17206835
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Multiple behavioral risk factors for colorectal cancer and colorectal cancer screening status.
    Coups EJ; Manne SL; Meropol NJ; Weinberg DS
    Cancer Epidemiol Biomarkers Prev; 2007 Mar; 16(3):510-6. PubMed ID: 17372246
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Impact of mammography on U.S. breast cancer mortality, 1975-2000: are intermediate outcome measures informative?
    Habbema JD; Tan SY; Cronin KA
    J Natl Cancer Inst Monogr; 2006; (36):105-11. PubMed ID: 17032900
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Genome-scale loss-of-function screening with a lentiviral RNAi library.
    Root DE; Hacohen N; Hahn WC; Lander ES; Sabatini DM
    Nat Methods; 2006 Sep; 3(9):715-9. PubMed ID: 16929317
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The interdependence between screening methods and screening libraries.
    Shelat AA; Guy RK
    Curr Opin Chem Biol; 2007 Jun; 11(3):244-51. PubMed ID: 17524728
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Screening isolates from antibody phage-display libraries.
    Buckler DR; Park A; Viswanathan M; Hoet RM; Ladner RC
    Drug Discov Today; 2008 Apr; 13(7-8):318-24. PubMed ID: 18405844
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Kinase inhibitor data modeling and de novo inhibitor design with fragment approaches.
    Vieth M; Erickson J; Wang J; Webster Y; Mader M; Higgs R; Watson I
    J Med Chem; 2009 Oct; 52(20):6456-66. PubMed ID: 19791746
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Assessing the scaffold diversity of screening libraries.
    Krier M; Bret G; Rognan D
    J Chem Inf Model; 2006; 46(2):512-24. PubMed ID: 16562979
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Screening libraries--the seven ages.
    Crossley R
    IDrugs; 2001 May; 4(5):481-2. PubMed ID: 16012879
    [No Abstract]   [Full Text] [Related]  

  • 38. Library fingerprints: a novel approach to the screening of virtual libraries.
    Klon AE; Diller DJ
    J Chem Inf Model; 2007; 47(4):1354-65. PubMed ID: 17595072
    [TBL] [Abstract][Full Text] [Related]  

  • 39.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 40.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 3.